UNSPSC 51422201: Fluocinonide

This classification denotes a therapeutic glucocorticoid with the molecular formula C26H32F2O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2W4A77YPAN, chemically known as 6.alpha.,9-difluoro-11.beta.,16.alpha., 17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16, 17-acetal with acetone, 21-acetate but generally known as fluocinonide, which bears US NIH Compound Identifier 3382. European Medicines Agency schedules Fluocinonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07715MIG.

UNSPSC 51422201 Fluocinonide is a Commodity code that nominally designates a topical corticosteroid medication, but the recent state and local procurement activity tagged under it does not reflect pharmaceutical inventory. Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, solicits procurement of naloxone and drug deactivation systems—products unrelated to fluocinonide's scope. The mismatch suggests either a classification error in the county's tagging or that this code sees limited relevant state and local solicitation activity in the current procurement environment. State and local health departments and counties may use this code when acquiring corticosteroid medications for clinic stock, emergency medical supplies, or formulary agreements, but the available record offers no evidence of such activity.

The source provides only a single opportunity, which is misclassified relative to the code's stated scope. No recent opportunities for fluocinonide procurement appear in the available data. Without additional records from health departments, state purchasing cooperatives, or regional pharmacy networks, the geographic distribution, issuing-body patterns, and representative scope of work under this Commodity code cannot be reliably characterized. Buyers evaluating this code should conduct targeted outreach to state health agency procurement offices, county health departments, and cooperative purchasing organizations in their regions to establish whether fluocinonide demand exists under this classification or whether procurement is routed through different UNSPSC codes or standing pharmaceutical agreements.